We are live on
!
Find out more
SL
Stevard LLC Portfolio holdings
AUM
$26.8M
1-Year Est. Return
42.43%
This Fund
S&P 500
This Quarter
Est. Return
-5.6%
1 Year Est. Return
+42.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.9M
AUM Growth
-$6.28M
(-6%)
Cap. Flow
+$58.1K
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
80.55%
Holding
45
New
1
Increased
10
Reduced
12
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$404K |
| 2 |
IBM
IBM
|
+$205K |
| 3 |
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
|
+$64.1K |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$19.1K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$14.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$289K |
| 2 |
CRISPR Therapeutics
CRSP
|
+$245K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$69.9K |
| 4 |
Pfizer
PFE
|
+$27.6K |
| 5 |
ARK Genomic Revolution ETF
ARKG
|
+$14.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.09% |
| 2 | Technology | 11.25% |
| 3 | Consumer Discretionary | 4.77% |
| 4 | Financials | 3.22% |
| 5 | Materials | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$1.07T
| $527K | 0.53% |
982
| – | – |
|
27
AstraZeneca
AZN
$263B
| $491K | 0.5% |
3,624
| – | – |
|
|
28
Schwab US Dividend Equity ETF
SCHD
$102B
| $453K | 0.46% |
19,197
-11,757
| -38% | -$289K |
|
29
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
| $434K | 0.44% |
3,106
| – | – |
|
30
ARK Web x.0 ETF
ARKW
$1.64B
| $421K | 0.43% |
7,767
-17
| -0.2% | -$1.01K |
|
|
31
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
| $381K | 0.38% |
3,944
+128
| +3% | +$19.1K |
|
32
ARK Innovation ETF
ARKK
$5.89B
| $330K | 0.33% |
8,321
-23
| -0.3% | -$1.01K |
|
33
Devon Energy
DVN
$51.9B
| $326K | 0.33% |
6,842
| – | – |
|
34
Renaissance IPO ETF
IPO
$154M
| $288K | 0.29% |
9,010
| – | – |
|
35
Intel
INTC
$466B
| $287K | 0.29% |
8,072
| – | – |
|
36
Deere & Co
DE
$170B
| $265K | 0.27% |
703
| – | – |
|
|
37
ARK Genomic Revolution ETF
ARKG
$1.51B
| $256K | 0.26% |
9,199
-443
| -5% | -$14.5K |
|
38
Sunrun
RUN
$2.37B
| $254K | 0.26% |
20,258
+75
| +0.4% | +$1.23K |
|
39
Invesco Solar ETF
TAN
$1.47B
| $252K | 0.26% |
4,871
| – | – |
|
40
Vanguard Consumer Staples ETF
VDC
$7.86B
| $251K | 0.25% |
1,373
| – | – |
|
|
41
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$633M
| $250K | 0.25% |
5,856
+1,313
| +29% | +$64.1K |
|
42
Fortinet
FTNT
$112B
| $244K | 0.25% |
4,150
-20
| -0.5% | -$1.32K |
|
|
43
iShares Russell 2000 ETF
IWM
$80.9B
| $204K | 0.21% |
1,157
+77
| +7% | +$14.5K |
|
|
44
IBM
IBM
$202B
| $202K | 0.2% |
+1,443
| New | +$205K |
|
|
45
CRISPR Therapeutics
CRSP
$4.58B
| – | – |
-4,356
| Closed | -$245K |
|
Similar funds
SFM
CGI
VFA
MFAM
AH
VCM
CIA
CIM
Stevard LLC's Q3 2023 Portfolio in Review
As of Q3 2023, Stevard LLC held 45 positions worth $98.9M, down 6% from $105M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.4%. Stevard LLC opened 1 new position and exited 1, leaving the 45-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Technology and Consumer Discretionary.
- Stevard LLC's largest Q3 2023 buy was IBM: 1,443 shares worth $202K.
- Stevard LLC added most to Berkshire Hathaway Class B in Q3 2023, an estimated $404K increase.
- Stevard LLC's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $289K.
- Stevard LLC fully exited CRISPR Therapeutics in Q3 2023, selling an estimated $245K.
- Stevard LLC's ten largest holdings make up 81% of its $98.9M portfolio in Q3 2023.
- Stevard LLC opened 1 new position and closed 1 in Q3 2023.
- Stevard LLC's portfolio value fell 6% quarter-over-quarter to $98.9M.
Based on Stevard LLC's 13F filing for Q3 2023, filed 14 Nov 2023.